Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Share-based Compensation (2020 - 2023)

Historic Share-based Compensation for Terns Pharmaceuticals (TERN) over the last 4 years, with Q4 2023 value amounting to $3.3 million.

  • Terns Pharmaceuticals' Share-based Compensation rose 2214.37% to $3.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $25.5 million, marking a year-over-year increase of 13714.71%. This contributed to the annual value of $15.6 million for FY2024, which is 3880.4% down from last year.
  • Latest data reveals that Terns Pharmaceuticals reported Share-based Compensation of $3.3 million as of Q4 2023, which was up 2214.37% from $14.1 million recorded in Q3 2023.
  • Over the past 5 years, Terns Pharmaceuticals' Share-based Compensation peaked at $14.1 million during Q3 2023, and registered a low of $190000.0 during Q2 2020.
  • Over the past 4 years, Terns Pharmaceuticals' median Share-based Compensation value was $2.6 million (recorded in 2021), while the average stood at $2.9 million.
  • Per our database at Business Quant, Terns Pharmaceuticals' Share-based Compensation soared by 90473.68% in 2021 and then soared by 537.25% in 2022.
  • Over the past 4 years, Terns Pharmaceuticals' Share-based Compensation (Quarter) stood at $786000.0 in 2020, then skyrocketed by 224.43% to $2.6 million in 2021, then increased by 5.37% to $2.7 million in 2022, then rose by 22.14% to $3.3 million in 2023.
  • Its last three reported values are $3.3 million in Q4 2023, $14.1 million for Q3 2023, and $4.2 million during Q2 2023.